Taysha Gene Therapies Inc.

NASDAQ: TSHA
Share price (12/20/24): $1.85
Market cap (12/20/24): $379 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

ended 09/30/23 Q3

Prospectuses and Registrations Filter

Shelf registration

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Registration of securities for employees

Ownership Filter

Venrock Healthcare Capital Partners III, L.P.

Ra Capital Management, L.P.

Avoro Capital Advisors LLC

News Filter

Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

Announces Positive Clinical Data Across Adult and Pediatric Patients From Low Dose Cohort in Ongoing REVEAL Phase 1/2 Trials Evaluating TSHA-102 in Rett Syndrome

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC